Stockreport

Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1) [Yahoo! Finance]

Dyne Therapeutics, Inc.  (DYN) 
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm Check Earnings Report
US:NYSE Investor Relations: dynegy.com/investors/presentations-events
PDF Dyne Therapeutics, Inc. - HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 - 48-week trial will enroll approximately [Read more]